Medicinal product name Migard 2.5 mg film-coated tablets
Pharmaceutical form Film-coated tablet
Strength 2.5 mg 
Information from the MAH on shortages No information on expected shortages
Legal status Rx Prescription (Pr.)
Package leafletMS Word document 10-06-2021
Summary of product characteristicsMS Word document 10-06-2021
ATC code N02CC07 Analgesics

Medicinal products (12)

Availability of medicinal product Wholesalers Package size, content Primary packaging Maximum admissible pharmacy price (€ incl. VAT) Product No. Labelling
 Not available (according to the information provided by wholesalers)
Permitted to distribute until Jun 9, 2024
Product suspended from the medicinal product register, distribution permitted for a limited time span
currently no information on availability from any wholesaler N2
(2,5 mg)
PVC/PE/Aclar/aluminium blister 11.87  05-0053-01
 Not available (according to the information provided by wholesalers)
Permitted to distribute until Jun 9, 2024
Product suspended from the medicinal product register, distribution permitted for a limited time span
currently no information on availability from any wholesaler N3
(2,5 mg)
PVC/PE/Aclar/aluminium blister    05-0053-02
 Not available (according to the information provided by wholesalers)
Permitted to distribute until Jun 9, 2024
Product suspended from the medicinal product register, distribution permitted for a limited time span
currently no information on availability from any wholesaler N6
(2,5 mg)
PVC/PE/Aclar/aluminium blister    05-0053-03
 Not available (according to the information provided by wholesalers)
Permitted to distribute until Jun 9, 2024
Product suspended from the medicinal product register, distribution permitted for a limited time span
currently no information on availability from any wholesaler N12
(2,5 mg)
PVC/PE/Aclar/aluminium blister    05-0053-04
 Not available (according to the information provided by wholesalers)
Permitted to distribute until Jun 9, 2024
Product suspended from the medicinal product register, distribution permitted for a limited time span
currently no information on availability from any wholesaler N1
(2,5 mg)
PVC/PE/Aclar/aluminium blister    05-0053-05
 Not available (according to the information provided by wholesalers)
Permitted to distribute until Jun 9, 2024
Product suspended from the medicinal product register, distribution permitted for a limited time span
currently no information on availability from any wholesaler N4
(2,5 mg)
PVC/PE/Aclar/aluminium blister    05-0053-06
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N1
(2,5 mg)
PVC/PE/PVDC/Al blister    05-0053-08 Labelling text Labelling text Jun 8, 2021
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N2
(2,5 mg)
PVC/PE/PVDC/Al blister 11.87  05-0053-09 Labelling text Labelling text Jun 8, 2021
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N3
(2,5 mg)
PVC/PE/PVDC/Al blister    05-0053-10 Labelling text Labelling text Jun 8, 2021
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N4
(2,5 mg)
PVC/PE/PVDC/Al blister    05-0053-11 Labelling text Labelling text Jun 8, 2021
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N6
(2,5 mg)
PVC/PE/PVDC/Al blister    05-0053-12 Labelling text Labelling text Jun 8, 2021
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N12
(2,5 mg)
PVC/PE/PVDC/Al blister    05-0053-13 Labelling text Labelling text Jun 8, 2021

Registration information

Marketing authorisation No. 05-0053
Date of authorisation Mar 8, 2005
Marketing authorisation holder, country Menarini International Operations Luxembourg S.A., Luxembourg